🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,760 results for “Pharm” Clear

  1. sulopenem etzadroxil and probenecid

    Iterum Therapeutics plc

    Pharmacokinetics After Oral Intake

    phase 1 small molecule active

    1 trial

  2. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  3. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol

    phase 1 small molecule completed

    1 trial

  4. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Circadian Rhythm Sleep Disorders

    phase 1 small molecule completed

    1 trial

  5. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial

  6. teduglutide

    Takeda

    Pharmacokinetics and Safety of Elevated Doses

    phase 1 small molecule completed

    1 trial

  7. telaprevir (VX-950)

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatic Insufficiency

    phase 1 small molecule completed

    1 trial

  8. telaprevir formulation A

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  9. telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Kidney Diseases

    phase 1 small molecule completed

    1 trial

  10. tradipitant

    Vanda Pharmaceuticals Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. warfarin sodium

    IONIS PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  12. yimitasvir

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis c

    phase 1 small molecule completed

    1 trial

  13. zelicapavir (therapeutic dose)

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 1 small molecule completed

    1 trial

  14. -, -, SULFAMETHOXAZOLE AND TRIMETHOPRIM

    Pari Pharma GmbH

    Pyelonephritis, Kidney Transplant recipients

    approved small molecule active

    1 trial

  15. -, IPTACOPAN, -, -, -

    Novartis Pharmaceuticals

    IgA Nephropathy

    approved small molecule active

    1 trial

  16. 100mg SPN-812

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule active

    1 trial

  17. 16 mg buprenorphine with 4 mg naloxone sublingual film

    Teva Pharma GmbH

    Evaluation of QTc Interval

    approved other terminated

    1 trial

  18. 2wIPV+1sIPV

    Biotech Pharmaceutical Co.,

    Poliomyelitis

    approved mab active

    1 trial

  19. ADVAGRAF

    Astellas Pharma Inc

    Renal Transplantation

    approved small molecule completed

    1 trial

  20. ADZENYS XR-ODT

    AYTU BIOPHARMA, INC

    Attention Deficit Hyperactivity Disorder

    approved small molecule terminated

    1 trial

  21. AGAMREE 40 mg/ml oral suspension

    Lacuna Pharma Pty Ltd

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial

  22. AGEE cream

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule terminated

    1 trial

  23. AMOXICILLIN

    Pari Pharma GmbH

    Adults diagnosed with lower limbs erysipelas

    approved small molecule active

    1 trial

  24. AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CEFEPIME , CEFOTAXIME, SPIRAMYCIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR

    Pari Pharma GmbH

    EA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy).

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources